Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 8
- Industry Trends
Is Portugal About to Lose its Position as the ‘Gateway’ to Europe’s Largest Cannabis Markets?
Over the last five years, Portugal has built a reputation as the medical cannabis ‘doorway to Europe’, the go-to hub for countries from North and South America, Asia and Oceania to ship their cannabis to and have it distributed to Europe’s most active markets.
- Medical Cannabis
Curaleaf Laboratories Enters Strategic Partnership with ANTG to Manufacture and Distribute Medicinal Cannabis Products in the UK
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis.
- Medical Cannabis
SOMAÍ Adds International Lifestyle Brand Cookies to Global Medical Cannabis Markets
Cookies, the most globally recognised cannabis brand, is entering global medical markets with a full extract portfolio through a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO).
- Clinical Research
The Evidence Pyramid: Understanding Cannabis Research
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not all evidence carries the same scientific weight.
- Medical Cannabis
Cannabis Group Cannim Collapses: UK Clinics Pause, Creditors Pursue Millions
Cannim Group Pty, the international medical cannabis company with operations spanning the UK, Australia, the US and Canada, has entered voluntary administration.
- Industry Trends
New Data Shows UK Medical Cannabis Industry Still Has a Gender Problem
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well behind its peers in one key area, data.
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- Clinical Research
How Cannabis Interacts with Pain, Sleep & Anxiety
Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and a growing demand for alternatives to conventional pharmaceuticals.
- Medical Cannabis
Germany Expands Its Medical Cannabis Import Cap as Australia Moves to Cut Back
Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets.
- Medical Cannabis
ACCM Launches National Partnerships to Expand Medical Cannabis Access and Insurance Coverage
The American Council of Cannabis Medicine (ACCM) has announced the launch of a new nationwide initiative with major insurers, healthcare systems, and associations to expand affordable access to medically guided cannabis treatment across the United States.
- Medical Cannabis
California Medical Cannabis Home Delivery Bill Vetoed by Governor Newsom
California Governor Gavin Newsom has vetoed legislation that would have allowed certain cannabis microbusinesses to ship medical products directly to patients using common carriers such as FedEx and UPS, citing concerns that the proposed system would be ‘burdensome and overly complex to administer’.
- International Regulation
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow nearly tenfold in just three years, according to new official data.
